Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections
Clinical trial NCT02134301 · COMPLETED
Trial details
- NCT number
- NCT02134301
- Sponsor
- Melinta Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2025-11-04
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.